Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan

Details for Australian Patent Application No. 2002354848 (hide)

Owner MERCK PATENT GMBH

Inventors Bachmann, Christiane; Mahler, Hanns-Christian; Martini-Marr, Ulrike; Haas, Udo; Muller, Robert

Agent Davies Collison Cave

Pub. Number AU-A-2002354848

PCT Number PCT/EP02/06696

PCT Pub. Number WO2003/007988

Priority 101 33 394.3 13.07.01 DE

Filing date 18 June 2002

Wipo publication date 3 March 2003

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 101 33 394.3 13.07.01 DE

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002354848

2 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002354849-SECONDARY 1,3-THIAZOLE-5-YL SULFONAMIDE DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS

2002354847-METHOD FOR PROTECTING A FLOORING OR LINING MATERIAL FROM STAINING SUBSTANCES